SEC Form 4 · accession 0001543209-15-000002
ARGOS THERAPEUTICS INC · ARGS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles A. Nicolette
Officer — Chief Scientific Officer
Period of report
Aug 20, 2015
Accepted (ET)
Aug 27, 2015 · 10:07 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001105533
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 20, 2015 | P | 5,000 | $6.45 | A | 13,130 | D |
Table II — derivative securities
No Table II lines on this filing.